GLOBAL BOTULINUM TOXIN MARKET 2021-2028

 

 

TABLE OF CONTENTS

 

1.     GLOBAL BOTULINUM TOXIN MARKET – SUMMARY    

2.     INDUSTRY OUTLOOK

1.1. KEY INSIGHTS     

1.1.1.    SURGE IN DISPOSABLE INCOME       

1.1.2.    GROWING NUMBER OF MEN OPTING FOR COSMETIC TREATMENT  

1.1.3.    DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE    

1.2. IMPACT OF COVID-19 ON THE BOTULINUM TOXIN INDUSTRY 

1.3. PORTER’S FIVE FORCES ANALYSIS 

1.1.4.    THREAT OF NEW ENTRANTS   

1.1.5.    THREAT OF SUBSTITUTE         

1.1.6.    BARGAINING POWER OF SUPPLIERS

1.1.7.    BARGAINING POWER OF BUYERS     

1.1.8.    THREAT OF COMPETITIVE RIVALRY  

1.4. MARKET ATTRACTIVENESS MATRIX

1.5. VENDOR SCORECARD  

1.6. KEY MARKET STRATEGIES     

1.1.9.    NEW PRODUCT LAUNCHES     

1.7. MARKET DRIVERS         

1.1.10.                    INCREASING DEMAND FOR AESTHETIC PROCEDURES         

1.1.11.                    EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS    

1.8. MARKET RESTRAINTS   

1.1.12.                    ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN  

1.1.13.                    LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES 

1.1.14.                    LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS  

1.9. MARKET OPPORTUNITIES      

1.1.15.                    INCREASING AGING POPULATION    

1.1.16.                    RISE IN MEDICAL TOURISM     

1.     GLOBAL BOTULINUM TOXIN MARKET – BY TYPE       

1.10.               TYPE A       

1.11.               TYPE B       

1.     GLOBAL BOTULINUM TOXIN MARKET – BY APPLICATION   

1.12.               COSMETIC APPLICATIONS       

1.1.17.                    GLABELLAR LINES         

1.1.18.                    LATERAL CANTHAL LINES (CROW’S FEET) 

1.1.19.                    FOREHEAD LINES

1.1.20.                    OTHER COSMETIC APPLICATIONS    

1.13.               NON-COSMETIC APPLICATIONS        

1.1.21.                    DYSTONIA  

1.1.22.                    CHRONIC MIGRAINE      

1.1.23.                    OPHTHALMOLOGIC DISORDERS       

1.1.24.                    OTHER NON-COSMETIC APPLICATIONS     

1.     GLOBAL BOTULINUM TOXIN MARKET – BY END-USER        

1.14.               HOSPITALS 

1.15.               CLINICS AND OTHERS   

1.     GLOBAL BOTULINUM TOXIN MARKET – REGIONAL OUTLOOK      

1.16.               NORTH AMERICA 

1.1.25.                    MARKET BY TYPE

1.1.26.                    MARKET BY APPLICATION       

1.1.26.1.    MARKET BY COSMETIC APPLICATIONS      

1.1.26.2.    MARKET BY NON-COSMETIC APPLICATIONS        

1.1.27.                    MARKET BY END-USER  

1.1.28.                    COUNTRY ANALYSIS      

1.1.28.1.    UNITED STATES   

1.1.28.2.    CANADA      

1.17.               EUROPE     

1.1.29.                    MARKET BY TYPE

1.1.30.                    MARKET BY APPLICATION       

1.1.30.1.    MARKET BY COSMETIC APPLICATIONS      

1.1.30.2.    MARKET BY NON-COSMETIC APPLICATIONS        

1.1.31.                    MARKET BY END-USER  

1.1.32.                    COUNTRY ANALYSIS      

1.1.32.1.    UNITED KINGDOM

1.1.32.2.    GERMANY  

1.1.32.3.    FRANCE      

1.1.32.4.    SPAIN         

1.1.32.5.    ITALY

1.1.32.6.    RUSSIA       

1.1.32.7.    REST OF EUROPE

1.18.               ASIA-PACIFIC       

1.1.33.                    MARKET BY TYPE

1.1.34.                    MARKET BY APPLICATION       

1.1.34.1.    MARKET BY COSMETIC APPLICATIONS      

1.1.34.2.    MARKET BY NON-COSMETIC APPLICATIONS        

1.1.35.                    MARKET BY END-USER  

1.1.36.                    COUNTRY ANALYSIS      

1.1.1.1.        CHINA         

1.1.1.2.        JAPAN         

1.1.1.3.        INDIA

1.1.1.4.        SOUTH KOREA     

1.1.1.5.        ASEAN COUNTRIES        

1.1.1.6.        AUSTRALIA & NEW ZEALAND   

1.1.1.7.        REST OF ASIA-PACIFIC  

1.19.               LATIN AMERICA    

1.1.37.                    MARKET BY TYPE

1.1.38.                    MARKET BY APPLICATION       

1.1.38.1.    MARKET BY COSMETIC APPLICATIONS      

1.1.38.2.    MARKET BY NON-COSMETIC APPLICATIONS        

1.1.39.                    MARKET BY END-USER            

1.1.40.                    COUNTRY ANALYSIS      

1.1.40.1.    BRAZIL        

1.1.40.2.    MEXICO      

1.1.40.3.    REST OF LATIN AMERICA        

1.20.               MIDDLE EAST AND AFRICA      

1.1.41.                    MARKET BY TYPE

1.1.42.                    MARKET BY APPLICATION       

1.1.42.1.    MARKET BY COSMETIC APPLICATIONS      

1.1.42.2.    MARKET BY NON-COSMETIC APPLICATIONS        

1.1.43.                    MARKET BY END-USER            

1.1.44.                    COUNTRY ANALYSIS      

1.1.1.1.        UNITED ARAB EMIRATES         

1.1.1.2.        TURKEY      

1.1.1.3.        SAUDI ARABIA      

1.1.1.4.        SOUTH AFRICA    

1.1.1.5.        REST OF MIDDLE EAST & AFRICA     

1.     COMPETITIVE LANDSCAPE 

1.1. ABBVIE INC

1.2. EVOLUS INC

1.3. GALDERMA PHARMA SA (ACQUIRED BY EQT)     

1.4. HUGEL INC

1.5. IPSEN PHARMA   

1.6. MERZ PHARMA    

1.7. MEDYTOX INC

1.8. REVANCE THERAPEUTICS INC

1.9. US WORLDMEDS LLC    

2.     METHODOLOGY & SCOPE  

1.1. RESEARCH SCOPE & DELIVERABLES        

1.2. SOURCES OF DATA      

1.3. RESEARCH METHODOLOGY  

 

 

LIST OF TABLES

TABLE 1: GLOBAL BOTULINUM TOXIN MARKET, BY REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2: MARKET ATTRACTIVENESS MATRIX

TABLE 3: VENDOR SCORECARD

TABLE 4: LIST OF NEW PRODUCT LAUNCHES

TABLE 5: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 6: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 8: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 9: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 10: GLOBAL BOTULINUM TOXIN MARKET, BY REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 11: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 12: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 13: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 14: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 15: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 16: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 17: EUROPE BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 18: EUROPE BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 19: EUROPE BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 20: EUROPE BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 21: EUROPE BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 22: EUROPE BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 23: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 24: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 25: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 26: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 27: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 28: ASIA-PACIFIC BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 29: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 30: LATIN AMERICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 31: LATIN AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 32: LATIN AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 33: LATIN AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 34: LATIN AMERICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 35: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 36: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 37: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 38: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 39: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

TABLE 40: MIDDLE EAST AND AFRICA BOTULINUM TOXIN MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

 

 

LIST OF FIGURES

 

FIGURE 1: PORTER’S FIVE FORCES ANALYSIS

FIGURE 2: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE, 2020 & 2028

FIGURE 3: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 4: GLOBAL BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 5: GLOBAL BOTULINUM TOXIN MARKET, BY APPLICATION, 2020 & 2028

FIGURE 6: GLOBAL BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 7: GLOBAL BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 8: GLOBAL BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 9: GLOBAL BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 10: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 11: GLOBAL BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 12: GLOBAL BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 13: GLOBAL BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 14: GLOBAL BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 16: GLOBAL BOTULINUM TOXIN MARKET, BY END-USER, 2020 & 2028

FIGURE 17: GLOBAL BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 18: GLOBAL BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 19: GLOBAL BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 20: UNITED STATES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 21: CANADA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 22: UNITED KINGDOM BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 23: GERMANY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 24: FRANCE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 25: SPAIN BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 26: ITALY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 27: RUSSIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: REST OF EUROPE BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: CHINA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 30: JAPAN BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 31: INDIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 32: SOUTH KOREA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 33: ASEAN COUNTRIES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 34: AUSTRALIA & NEW ZEALAND BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 35: REST OF ASIA-PACIFIC BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 36: BRAZIL BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 37: MEXICO BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 38: REST OF LATIN AMERICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 39: UNITED ARAB EMIRATES BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 40: TURKEY BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 41: SAUDI ARABIA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 42: SOUTH AFRICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

FIGURE 43: REST OF MIDDLE EAST & AFRICA BOTULINUM TOXIN MARKET 2021-2028 (IN $ MILLION)

 

 

 

MARKET OUTLOOK

 

After analyzing the global botulinum toxin market in detail, Triton Market Research has concluded that it would display an upward trend in terms of revenue, with a CAGR of 5.55% in the forecast period between 2021 and 2028.

The major driving forces behind this industry’s growth include the surging demand for aesthetic procedures and the extended applications of botulinum toxin into therapeutics. However, the side-effects resulting due to the use of botulinum toxin are majorly hampering its demand. Further, several countries do not have proper reimbursement policies in place for supporting cosmetic procedures. This, along with the lack of interchangeability between these products, is impeding the growth of the studied market. On a positive note, however, factors such as a rise in the aging population and growth in medical tourism offer multiple growth opportunities to the botulinum toxin market.

 

 

REGIONAL OUTLOOK

 

The global market for botulinum toxin spans across the regions of Latin America, the Asia-Pacific, the Middle East and Africa, North America, and Europe.

The market in the Asia-Pacific is expected to grow the fastest in the coming years, at a global level. This can be attributed to the aging demographics and the increasing disposable income of people, which have created a higher demand for anti-aging products. Moreover, the growing social awareness about the commercial availability of these products is anticipated to augment the market growth in the APAC in the near future.

 

 

COMPETITIVE OUTLOOK

 

The top companies that have been studied in the botulinum toxin market include US WorldMeds LLC, Ipsen Pharma, Evolus Inc, Medytox Inc, Galderma Pharma SA (Acquired By EQT), Hugel Inc, Revance Therapeutics Inc, Merz Pharma, and Abbvie Inc (Allergan Plc).

Allergan is a globally renowned pharmaceutical company operating in more than 100 countries, and boasts of 40 manufacturing facilities, 27 R&D centers, and numerous sales/marketing facilities in these regions. The company mainly focuses on the development, manufacturing, and commercialization of branded pharma devices, biologics, and regenerative & surgical medicine products for patients across the globe. It operates through three main business segments: US General Medicine, US Specialized Therapeutics, and International. Allergan has been strengthening and expanding its product portfolio with various launches and approvals, and its botulinum toxin products have received approval from the FDA.

 

Get more insights into the Global Botulinum Toxin Market:

 

https://www.tritonmarketresearch.com/reports/botulinum-toxin-market

 

 

SEGMENTATION

1.     ABBVIE INC     

2.     EVOLUS INC

3.     GALDERMA PHARMA SA (ACQUIRED BY EQT) 

4.     HUGEL INC

5.     IPSEN PHARMA         

6.     MERZ PHARMA

7.     MEDYTOX INC

8.     REVANCE THERAPEUTICS INC

9.     US WORLDMEDS LLC

Comments

Post a Comment

Popular posts from this blog

NORTH AMERICA BIOCHAR MARKET 2022-2028

    TABLE OF CONTENTS 1. NORTH AMERICA BIOCHAR MARKET - SUMMARY 2. INDUSTRY OUTLOOK 2.1. IMPACT OF COVID-19 ON BIOCHAR MARKET 2.2. KEY INSIGHTS 2.2.1. PYROLYSIS IS THE MOST COMMON TECHNIQUE FOR BIOCHAR PRODUCTION 2.2.2. AGRICULTURE DOMINATES THE APPLICATION SEGMENT 2.2.3. GROWING NEED TO AVOID BIOCHAR LOSS DURING APPLICATION AND TRANSPORTATION 2.3. PORTER’S FIVE FORCES ANALYSIS 2.3.1. THREAT OF NEW ENTRANTS 2.3.2. THREAT OF SUBSTITUTES 2.3.3. BARGAINING POWER OF BUYERS 2.3.4. BARGAINING POWER OF SUPPLIERS 2.3.5. THREAT OF COMPETITIVE RIVALRY 2.4. KEY IMPACT ANALYSIS 2.5. MARKET ATTRACTIVENESS INDEX 2.6. VENDOR SCORECARD 2.7. INDUSTRY COMPONENTS 2.8. REGULATORY FRAMEWORK 2.9. KEY MARKET STRATEGIES 2.9.1. PRODUCT LAUNCHES & DEVELOPMENTS 2.9.2. PARTNERSHIPS & AGREEMENTS 2.10. MARKET DRIVERS 2.10.1. FAVORABLE INITIATIVES 2.10.2. AVAILABILITY OF CHEAP FEEDSTOCK 2.10.3. ABILITY OF BIOCHAR TO SEQUESTER CARBON 2.10.4. RELIA...
Read more

ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET 2021-2026

    TABLE OF CONTENT 1.      ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET –SUMMARY 1.1. COUNTRY SNAPSHOT 1.2. MARKET SIZE & FORECAST 1.3. MARKET DRIVING ASPECTS 1.4. MARKET RESTRAINING ASPECTS 1.5. KEY PLAYERS 2.      ITALY ALCOHOLIC READY-TO-DRINKS (RTDS) MARKET OUTLOOK 2.1. IMPACT OF COVID-19 ON ITALY ALCOHOLIC RTDS MARKET 2.2. PESTLE ANALYSIS 2.2.1.     POLITICAL 2.2.2.     ECONOMICAL 2.2.3.     SOCIAL 2.2.4.     TECHNOLOGICAL 2.2.5.     LEGAL 2.2.6.     ENVIRONMENTAL 2.3. MARKET ATTRACTIVENESS INDEX 2.4. MARKET SHARE ANALYSIS OF KEY PLAYERS 2.5. BRAND SHARE ANALYSIS 3.      ITALY ALCOHOLIC RTD MARKET SEGMENTATION - BY RTD TYPE (IN TERMS OF VALUE: $ MILLION & IN TERMS OF VOLUME: MILLION LITRES) 3.1. SPIRIT-BASED RTDS 3.2. WINE-BASED RTDS 4.    ...
Read more

GLOBAL ENTERPRISE RESOURCE PLANNING MARKET 2022-2028

    TABLE OF CONTENTS   1.      GLOBAL ENTERPRISE RESOURCE PLANNING MARKET - SUMMARY 2.      INDUSTRY OUTLOOK 2.1. IMPACT OF COVID-19 ON ENTERPRISE RESOURCE PLANNING MARKET 2.2. PARENT MARKET ANALYSIS: ENTERPRISE APPLICATION MARKET 2.3. TIMELINE OF ENTERPRISE RESOURCE PLANNING (ERP) 2.4. KEY INSIGHTS 2.4.1.     EMERGENCE OF CLOUD ERP 2.4.2.     SOCIAL NETWORKING IS GAINING IMPORTANCE AMONG ERP MERCHANTS 2.4.3.     INTEGRATED ERP IS ONE OF THE PROMINENT EMERGING TRENDS 2.4.4.     ACQUISITION HAS EMERGED AS A PRIMARY GROWTH STRATEGY 2.5. PORTER’S FIVE FORCES ANALYSIS 2.5.1.     THREAT OF NEW ENTRANTS 2.5.2.     THREAT OF SUBSTITUTES 2.5.3.     BARGAINING POWER OF BUYERS 2.5.4.     BARGAINING POWER OF SUPPLIERS 2.5.5.     THREAT OF COMPETITIVE RIVALRY 2.6. KEY...
Read more